Can Starbucks' 600-650 New Stores Strengthen Its Global Growth?

Starbucks plans to add 600-650 net coffeehouses in fiscal 2026, supported primarily by international expansion; it ended fiscal Q3 with 22,933 international stores after adding 189 during the quarter. International company-operated comparable sales increased 5.7%, while roughly 90% of the overseas portfolio is now licensed following the China joint-venture transition; the China JV targets up to 20,000 stores over time. North American company-operated growth is expected to remain modest through fiscal 2027, but consensus fiscal 2026 EPS is projected to rise 21.6% year over year and has increased over the past 60 days.

Analysis

The investable issue is not unit count but the earnings-quality trade-off embedded in the licensing mix. A larger licensed portfolio lowers Starbucks' capital intensity and limits direct exposure to local labor and occupancy inflation, but it also converts store-level economics into lower-margin royalty revenue and gives partners more operating leverage. That can support free-cash-flow conversion over 6-18 months while capping the upside to consolidated margins versus a company-operated recovery.

At roughly 31x forward earnings, SBUX needs evidence that international development is incremental rather than cannibalistic and that its domestic remediation does not prolong the U.S. sales/margin reset. The next 1-3 months' catalyst is disclosure on licensed revenue growth, China JV economics, international transaction growth, and whether U.S. store closures/uplifts produce a measurable four-wall return. A miss on any of those measures risks multiple compression toward premium quick-service peers even if headline unit growth is delivered.

The contrarian read is that aggressive global restaurant development is more likely to pressure prime-site availability, construction costs, and wage competition than to create a broad demand tailwind. MCD's scale and franchisee model remain structurally better suited to defend returns during a consumer slowdown; CMG's overseas rollout is too early to justify assigning it meaningful near-term earnings value. SBUX's expansion narrative is therefore a validation event, not yet a new catalyst, because consensus already assumes a sharp earnings recovery.

Key Decisions for Investors

• Maintain SBUX as a watch/neutral rather than add exposure ahead of the next earnings release; initiate only if international licensed revenue and company-operated comparable sales both accelerate while FY2026 EPS guidance is maintained or raised. Falsifier: U.S. traffic remains weak or management signals further margin investment, which would make the current premium multiple vulnerable.
• Prefer a 3-6 month long MCD / short SBUX pair for defensive global restaurant exposure, sized to beta-neutral. MCD's franchise-heavy model should better preserve cash returns if development costs or international consumer demand weaken; exit if SBUX demonstrates sustained U.S. traffic recovery plus margin expansion sufficient to support consensus earnings.
• Avoid treating CMG's international pipeline as a near-term earnings catalyst. Reassess after partner economics, opening cadence, and unit-level returns are disclosed; until then, domestic comparable-sales trends and food/labor inflation remain the relevant drivers.
• Set an earnings-monitor alert for SBUX international transaction growth, China JV contribution, licensed segment margin/royalty disclosures, and North American store-level return metrics. Absence of these data points should prevent underwriting incremental value from the longer-dated development pipeline.